BigBear.ai tumbles as the AI company reports disappointing earnings and guidance, while Hanesbrands jumps following a report ...

Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and ...

Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty care platform with the acquisition of Solaris Health.

Cardinal Health shares slid after the drug wholesaler posted earnings shy of some investors' expectations, and unexpectedly agreed to acquire urology-supplies dealer Solaris Health for about $2.4 ...

Cardinal Health (CAH) is falling after announcing a $1.9 billion deal to acquire Solaris Health, aiming to expand in the ...

Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.